Impact of PD-L1 feedback modulation on the sensitivity of anti-PD-1/PD-L1

被引：0
|
作者：
Zhu, Jian [1 ]
Zhu, Rebecca L. [2 ]
机构：
[1] OmicsHealth LLC, Potomac, MD USA
[2] Winston Churchill High Sch, Potomac, MD USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-673
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
673
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
    Bai, Jie
    Gao, Zhitao
    Li, Xiang
    Dong, Liang
    Han, Weidong
    Nie, Jing
    [J]. ONCOTARGET, 2017, 8 (66) : 110693 - 110707
  • [32] Multiplex immunohistochemistry/immunofluorescence is superior to tumor mutational burden and PD-L1 immunohistochemistry for predicting response to anti-PD-1/PD-L1 immunotherapy
    Hu, Weixian
    [J]. THORACIC CANCER, 2020, 11 (01) : 3 - 5
  • [33] PD-L1
    Kythreotou, Anthousa
    Siddique, Abdul
    Mauri, Francesco A.
    Bower, Mark
    Pinato, David J.
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2018, 71 (03) : 189 - 194
  • [34] The IFN-γ/PD-L1 axis between T cells and tumor microenvironment: hints for glioma anti-PD-1/PD-L1 therapy
    Jiawen Qian
    Chen Wang
    Bo Wang
    Jiao Yang
    Yuedi Wang
    Feifei Luo
    Junying Xu
    Chujun Zhao
    Ronghua Liu
    Yiwei Chu
    [J]. Journal of Neuroinflammation, 15
  • [35] PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials
    Madore, Jason
    Vilain, Ricardo E.
    Menzies, Alexander M.
    Kakavand, Hojabr
    Wilmott, James S.
    Hyman, Jessica
    Yearley, Jennifer H.
    Kefford, Richard F.
    Thompson, John F.
    Long, Georgina V.
    Hersey, Peter
    Scolyer, Richard A.
    [J]. PIGMENT CELL & MELANOMA RESEARCH, 2015, 28 (03) : 245 - 253
  • [36] Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1/PD-L1 agents: A meta-analysis
    Abdel-Rahman, Omar
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 75 - 85
  • [37] PD-L1 Copy Number Variation Does Not Correlate With PD-L1 Expression or Response to Anti-PD-1 Immunotherapy In Patients With Advanced Melanomas
    Perottet, Jeremy
    Le Goff, Emeline
    Legoupil, Delphine
    Quere, Gilles
    Schick, Ulrike
    Marcorelles, Pascale
    Uguen, Arnaud
    [J]. APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (02) : 161 - 165
  • [38] Evaluating PD-L1 in Cytology to Determine Eligibility for Anti-PD-1/PD-L1 Immunotherapy in Patients with Head and Neck Squamous Cell Carcinoma
    Liu, Zhonghua
    Roy-Chowdhuri, Sinchita
    [J]. MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 246 - 247
  • [39] Evaluating PD-L1 in Cytology to Determine Eligibility for Anti-PD-1/PD-L1 Immunotherapy in Patients with Head and Neck Squamous Cell Carcinoma
    Liu, Zhonghua
    Roy-Chowdhuri, Sinchita
    [J]. LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 246 - 247
  • [40] Targeting regulatory T cells in anti-PD-1/PD-L1 cancer immunotherapy
    Zhulai, Galina
    Oleinik, Eugenia
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2022, 95 (03)
12345